Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12466152
[patent_doc_number] => 09987291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Synthetic bile acid compositions and methods
[patent_app_type] => utility
[patent_app_number] => 15/472135
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12570
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472135 | Synthetic bile acid compositions and methods | Mar 27, 2017 | Issued |
Array
(
[id] => 14069143
[patent_doc_number] => 20190083459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => PHARMACEUTICAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/085073
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085073 | PHARMACEUTICAL COMPOSITION AND USE THEREOF | Mar 23, 2017 | Abandoned |
Array
(
[id] => 13091097
[patent_doc_number] => 10064873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Compounds and compositions for treating HIV with derivatives of Betulin
[patent_app_type] => utility
[patent_app_number] => 15/464553
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 51563
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15464553
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/464553 | Compounds and compositions for treating HIV with derivatives of Betulin | Mar 20, 2017 | Issued |
Array
(
[id] => 14338587
[patent_doc_number] => 20190151266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES
[patent_app_type] => utility
[patent_app_number] => 16/095356
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095356 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES | Mar 5, 2017 | Abandoned |
Array
(
[id] => 11936438
[patent_doc_number] => 20170240587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'HETEROARYL CONTAINING BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/439531
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15423
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15439531
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/439531 | Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof | Feb 21, 2017 | Issued |
Array
(
[id] => 11936436
[patent_doc_number] => 20170240586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'Benzoic Acid Derivatives of Bile Acid as FXR/TGR5 Agonists and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/439303
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15086
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15439303
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/439303 | Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof | Feb 21, 2017 | Issued |
Array
(
[id] => 11936435
[patent_doc_number] => 20170240585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'DEUTERATED BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/439358
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14984
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15439358
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/439358 | Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | Feb 21, 2017 | Issued |
Array
(
[id] => 11834597
[patent_doc_number] => 20170216316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'FARNESOID X RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/434685
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14625
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434685
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/434685 | FARNESOID X RECEPTOR MODULATORS | Feb 15, 2017 | Abandoned |
Array
(
[id] => 19119980
[patent_doc_number] => 11963941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Use of a fasting mimicking diet to enhance the efficacy of antiestrogens in cancer
[patent_app_type] => utility
[patent_app_number] => 16/075187
[patent_app_country] => US
[patent_app_date] => 2017-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5841
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075187
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075187 | Use of a fasting mimicking diet to enhance the efficacy of antiestrogens in cancer | Feb 13, 2017 | Issued |
Array
(
[id] => 17111709
[patent_doc_number] => 20210292306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => NOVEL INDOLE DERIVATIVE AND ANTI-CANCER CONPOSITION CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 15/999066
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999066 | NOVEL INDOLE DERIVATIVE AND ANTI-CANCER CONPOSITION CONTAINING SAME | Feb 12, 2017 | Pending |
Array
(
[id] => 13898873
[patent_doc_number] => 20190038641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => COMBINATION THERAPY FOR CASTRATION-RESISTANT PROSTRATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/075355
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075355 | COMBINATION THERAPY FOR CASTRATION-RESISTANT PROSTRATE CANCER | Feb 2, 2017 | Abandoned |
Array
(
[id] => 12091121
[patent_doc_number] => 20170348214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS'
[patent_app_type] => utility
[patent_app_number] => 15/409494
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15183
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409494
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409494 | COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS | Jan 17, 2017 | Abandoned |
Array
(
[id] => 13196121
[patent_doc_number] => 10112970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Process for the preparation of 17-desoxy-corticosteroids
[patent_app_type] => utility
[patent_app_number] => 15/402028
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4013
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15402028
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/402028 | Process for the preparation of 17-desoxy-corticosteroids | Jan 8, 2017 | Issued |
Array
(
[id] => 12975703
[patent_doc_number] => 20170340651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING
[patent_app_type] => utility
[patent_app_number] => 15/399992
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399992
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/399992 | COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING | Jan 5, 2017 | Abandoned |
Array
(
[id] => 15604191
[patent_doc_number] => 10583135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Compositions for treating CMT and related disorders
[patent_app_type] => utility
[patent_app_number] => 15/390972
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 20059
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390972
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/390972 | Compositions for treating CMT and related disorders | Dec 26, 2016 | Issued |
Array
(
[id] => 12904342
[patent_doc_number] => 20180193289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => PROTOTYPICAL MOLECULAR PHARMACOLOGIC PROFILE OF FENDILINE AGAINST
NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/381338
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15381338
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/381338 | PROTOTYPICAL MOLECULAR PHARMACOLOGIC PROFILE OF FENDILINE AGAINST NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES | Dec 15, 2016 | Abandoned |
Array
(
[id] => 13606843
[patent_doc_number] => 20180354970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => PROCESS FOR THE PREPARATION OF TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS FOR USING THE SAME FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/780328
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780328
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780328 | Process for the preparation of tricyclic PI3K inhibitor compounds and methods for using the same for the treatment of cancer | Dec 15, 2016 | Issued |
Array
(
[id] => 15708555
[patent_doc_number] => 20200101043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => COMBINATIONS AND METHODS FOR THE TREATMENT OF NEUROPATHIC PAIN
[patent_app_type] => utility
[patent_app_number] => 16/469277
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469277 | Combinations and methods for the treatment of neuropathic pain | Dec 13, 2016 | Issued |
Array
(
[id] => 12001684
[patent_doc_number] => 20170305840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'SUBSTITUTED TETRACYCLINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/374329
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21211
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15374329
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/374329 | SUBSTITUTED TETRACYCLINE COMPOUNDS | Dec 8, 2016 | Abandoned |
Array
(
[id] => 15912895
[patent_doc_number] => 10653669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
[patent_app_type] => utility
[patent_app_number] => 15/781756
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 3161
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781756
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781756 | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | Dec 8, 2016 | Issued |